Stemcentrx For Profit
.jpg)
Seraxis is a privately owned biotechnology company.
Technology:
Pharmaceuticals
Industry:
Regenerative medicine
Headquarters:
United States
Investors Number:
11
Total Funding:
$700M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Register and Claim Ownership